Optimizing prognosis in atrial fibrillation: A call to action in Portugal

Jorge Ferreira1, Natália António2, Nuno Cortez-Dias3

  • 1Serviço de Cardiologia, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Carnaxide, Portugal.

Insights

Atrial fibrillation (AF) management has advanced with new anticoagulants, yet residual risks like stroke and bleeding persist. Early detection and comprehensive strategies are crucial for improving patient outcomes and prognosis.

Area of Science:

  • Cardiology
  • Thrombocardiology
  • Public Health

Background:

  • Atrial fibrillation (AF) is the most prevalent arrhythmia globally, causing significant cardiovascular mortality, morbidity, and economic burden.
  • Oral anticoagulation (OAC) is vital for stroke prevention in AF patients.
  • Non-vitamin K oral anticoagulants (NOACs) have revolutionized thrombocardiology, but residual vascular risks remain.

Purpose of the Study:

  • To review current epidemiological data on atrial fibrillation.
  • To discuss advancements in early AF detection and rhythm control strategies.
  • To explore optimal management of OAC, bleeding, and future prognostic improvements.

Main Methods:

  • Literature review of epidemiological data on AF.
  • Analysis of current tools for early AF detection.
  • Evaluation of catheter ablation for rhythm control.
  • Assessment of periprocedural OAC and bleeding management.

Main Results:

  • Significant residual vascular risks persist despite advances in AF treatment.
  • Silent AF, bleeding complications, sudden death, and heart failure are key concerns.
  • New tools and strategies are needed to mitigate these residual risks.

Conclusions:

  • Comprehensive management strategies are essential for improving AF prognosis.
  • Early detection, optimized anticoagulation, and risk factor management are critical.
  • Further research is needed to address residual risks and enhance patient outcomes.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
57
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
54
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
62
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
421
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
51